Plasma and serum lactoferrin levels in cystic fibrosis. Relationship with the presence of cystic fibrosis protein

Abstract

Plasma lactoferrin concentrations were measured in blood of cystic fibrosis patients, heterozygotes and controls using a specific and sensitive enzyme immunoassay. 67 plasmas were studied (26 controls, 23 heterozygotes, 18 cystic fibrosis patients) and the results showed a statistically significant increase ( p < 0.05) of the level of plasma lactoferrin in cystic fibrosis patients (265 ± 224 μg/l) compared to controls (168 ± 100 μg/l) and heterozygotes (150 ± 72 μg/l). Since it is well established that plasma lactoferrin level could be influenced by the number of neutrophils, a second set of experiments was performed on 20 cystic fibrosis patients on whom leukocyte counts were also made. When the 15 plasmas with normal neutrophils (in the range 2 to 6 giga/l) were considered, the mean lactoferrin level was 318 ± 116 μg/l, still far above the normal values. For serum, a similar significant increase of lactoferrin concentration was observed in 33 cystic fibrosis patients (610 ± 551 μg/l) compared to the values observed for 25 controls (237 ± 155 μg/l) and 37 heterozygotes (272 ± 231 μg/l). Cystic fibrosis protein (CFP) was identified in the same sera by isoelectric focusing and the intensity of the band was closely related to the increase of lactoferrin concentration in cystic fibrosis patients. In contrast, no difference in serum lactoferrin concentrations was observed between heterozygotes with or without CFP, indicating that the increased CFP concentration cannot be due only to altered granulocyte function.